Tango Therapeutics, Inc.
Nasdaq · Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
Tango Therapeutics is a clinical-stage biopharmaceutical company that uses genetic screening technology to identify cancer targets, developing small-molecule and other therapies aimed at genetically defined patient populations.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Newcomb JessicaPrincipal Accounting Officer | Sell | $122K | 5,100at $23.97 | Sep 22, 2026 |
| Newcomb JessicaPrincipal Accounting Officer | Sell | $60K | 2,400at $25.17 | Sep 22, 2026 |
| Newcomb JessicaPrincipal Accounting Officer | Sell | $16K | 700at $22.80 | Sep 22, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable TNGX activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.